Cargando…
The Clinical Impact of Imaging Surveillance and Clinic Visit Frequency after Acute Aortic Dissection
Background Guidelines recommend frequent follow-up after acute aortic dissection (AAD), but optimal rates of follow-up are not clear. Methods We examined rates of imaging and clinic visits in 267 individuals surviving AAD during recommended intervals (≤1, > 1–3, > 3–6, > 6–12 months, then...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical Publishers
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794145/ https://www.ncbi.nlm.nih.gov/pubmed/31614376 http://dx.doi.org/10.1055/s-0039-1692187 |
_version_ | 1783459233176485888 |
---|---|
author | Chaddha, Ashish Eagle, Kim A. Patel, Himanshu J. Deeb, G. Michael Yang, Bo Harris, Kevin M. Braverman, Alan C. Hutchison, Stuart Evangelista, Arturo Fattori, Rossella Froehlich, James B. Nienaber, Christoph A. Isselbacher, Eric M. Montgomery, Dan G. Kline-Rogers, Eva Woznicki, Elise LaBounty, Troy M. |
author_facet | Chaddha, Ashish Eagle, Kim A. Patel, Himanshu J. Deeb, G. Michael Yang, Bo Harris, Kevin M. Braverman, Alan C. Hutchison, Stuart Evangelista, Arturo Fattori, Rossella Froehlich, James B. Nienaber, Christoph A. Isselbacher, Eric M. Montgomery, Dan G. Kline-Rogers, Eva Woznicki, Elise LaBounty, Troy M. |
author_sort | Chaddha, Ashish |
collection | PubMed |
description | Background Guidelines recommend frequent follow-up after acute aortic dissection (AAD), but optimal rates of follow-up are not clear. Methods We examined rates of imaging and clinic visits in 267 individuals surviving AAD during recommended intervals (≤1, > 1–3, > 3–6, > 6–12 months, then annually), frequency of adverse imaging findings, and the relationship between follow-up and mortality. Results Type A and B AAD were noted in 46 and 54% of patients, respectively. Mean follow-up was 54.7 ± 13.3 months, with 52 deaths. Adverse imaging findings peaked at 6 to 12 months (5.6%), but rarely resulted in an intervention (3.4% peak at 6–12 months). Compared with those with less frequent imaging, patients with imaging for 33 to 66% of intervals ( p = 0.22) or ≥66% of intervals ( p = 0.77) had similar adjusted survival. In comparison to patients with fewer clinic visits, those with visits in 33 to 66% of intervals experienced lower adjusted mortality (hazards ratio: 0.47, 95% confidence interval: 0.23–0.97, p = 0.04), with no difference seen in those with ≥66% (vs. < 33%) interval visits ( p = 0.47). Imaging at 6 to 12 months (vs. none) was associated with decreased adjusted mortality (hazards ratio: 0.50, 95% confidence interval: 0.27–0.91, p = 0.02), while imaging during other intervals, or clinic visits during any specific intervals, was not associated with a difference in mortality ( p > 0.05 for each). Conclusions Adverse imaging findings following AAD are common, but rarely require prompt intervention. Patients with the lowest and highest rates of clinic visits experienced increased mortality. While the overall rate of surveillance imaging did not correlate with mortality, adverse imaging findings and related interventions peaked at 6 to 12 months after AAD, and imaging during this time was associated with improved survival. |
format | Online Article Text |
id | pubmed-6794145 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Thieme Medical Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-67941452019-10-16 The Clinical Impact of Imaging Surveillance and Clinic Visit Frequency after Acute Aortic Dissection Chaddha, Ashish Eagle, Kim A. Patel, Himanshu J. Deeb, G. Michael Yang, Bo Harris, Kevin M. Braverman, Alan C. Hutchison, Stuart Evangelista, Arturo Fattori, Rossella Froehlich, James B. Nienaber, Christoph A. Isselbacher, Eric M. Montgomery, Dan G. Kline-Rogers, Eva Woznicki, Elise LaBounty, Troy M. Aorta (Stamford) Background Guidelines recommend frequent follow-up after acute aortic dissection (AAD), but optimal rates of follow-up are not clear. Methods We examined rates of imaging and clinic visits in 267 individuals surviving AAD during recommended intervals (≤1, > 1–3, > 3–6, > 6–12 months, then annually), frequency of adverse imaging findings, and the relationship between follow-up and mortality. Results Type A and B AAD were noted in 46 and 54% of patients, respectively. Mean follow-up was 54.7 ± 13.3 months, with 52 deaths. Adverse imaging findings peaked at 6 to 12 months (5.6%), but rarely resulted in an intervention (3.4% peak at 6–12 months). Compared with those with less frequent imaging, patients with imaging for 33 to 66% of intervals ( p = 0.22) or ≥66% of intervals ( p = 0.77) had similar adjusted survival. In comparison to patients with fewer clinic visits, those with visits in 33 to 66% of intervals experienced lower adjusted mortality (hazards ratio: 0.47, 95% confidence interval: 0.23–0.97, p = 0.04), with no difference seen in those with ≥66% (vs. < 33%) interval visits ( p = 0.47). Imaging at 6 to 12 months (vs. none) was associated with decreased adjusted mortality (hazards ratio: 0.50, 95% confidence interval: 0.27–0.91, p = 0.02), while imaging during other intervals, or clinic visits during any specific intervals, was not associated with a difference in mortality ( p > 0.05 for each). Conclusions Adverse imaging findings following AAD are common, but rarely require prompt intervention. Patients with the lowest and highest rates of clinic visits experienced increased mortality. While the overall rate of surveillance imaging did not correlate with mortality, adverse imaging findings and related interventions peaked at 6 to 12 months after AAD, and imaging during this time was associated with improved survival. Thieme Medical Publishers 2019-10-15 /pmc/articles/PMC6794145/ /pubmed/31614376 http://dx.doi.org/10.1055/s-0039-1692187 Text en https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Chaddha, Ashish Eagle, Kim A. Patel, Himanshu J. Deeb, G. Michael Yang, Bo Harris, Kevin M. Braverman, Alan C. Hutchison, Stuart Evangelista, Arturo Fattori, Rossella Froehlich, James B. Nienaber, Christoph A. Isselbacher, Eric M. Montgomery, Dan G. Kline-Rogers, Eva Woznicki, Elise LaBounty, Troy M. The Clinical Impact of Imaging Surveillance and Clinic Visit Frequency after Acute Aortic Dissection |
title | The Clinical Impact of Imaging Surveillance and Clinic Visit Frequency after Acute Aortic Dissection |
title_full | The Clinical Impact of Imaging Surveillance and Clinic Visit Frequency after Acute Aortic Dissection |
title_fullStr | The Clinical Impact of Imaging Surveillance and Clinic Visit Frequency after Acute Aortic Dissection |
title_full_unstemmed | The Clinical Impact of Imaging Surveillance and Clinic Visit Frequency after Acute Aortic Dissection |
title_short | The Clinical Impact of Imaging Surveillance and Clinic Visit Frequency after Acute Aortic Dissection |
title_sort | clinical impact of imaging surveillance and clinic visit frequency after acute aortic dissection |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794145/ https://www.ncbi.nlm.nih.gov/pubmed/31614376 http://dx.doi.org/10.1055/s-0039-1692187 |
work_keys_str_mv | AT chaddhaashish theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT eaglekima theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT patelhimanshuj theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT deebgmichael theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT yangbo theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT harriskevinm theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT bravermanalanc theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT hutchisonstuart theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT evangelistaarturo theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT fattorirossella theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT froehlichjamesb theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT nienaberchristopha theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT isselbacherericm theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT montgomerydang theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT klinerogerseva theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT woznickielise theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT labountytroym theclinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT chaddhaashish clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT eaglekima clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT patelhimanshuj clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT deebgmichael clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT yangbo clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT harriskevinm clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT bravermanalanc clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT hutchisonstuart clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT evangelistaarturo clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT fattorirossella clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT froehlichjamesb clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT nienaberchristopha clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT isselbacherericm clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT montgomerydang clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT klinerogerseva clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT woznickielise clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection AT labountytroym clinicalimpactofimagingsurveillanceandclinicvisitfrequencyafteracuteaorticdissection |